Overview

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This study is a multi-center, open-label, dose escalation and expansion study of RLY-1971 in subjects with advanced or metastatic solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Hoffmann-La Roche
Relay Therapeutics, Inc.